24/02/2026
It’s indeed a great news. But the root of diabetes is not about lack of insulin in the very beginning. It is about that the insulin can’t trigger the opening of the door to let the glucose get inside our cells, so glucose stays in the blood causing high blood sugar.
Lack of insulin is a result of the exhausted pancreas which tried to produce more insulin to make the glucose door open but it never worked due to that the fat inside the cells blocks the communication between the insulin acceptor and the glucose door, so the door didn’t open.
The solution is to make the communication work again. That’s to remove the excessive fat inside the cell.
By reducing fat intake, no matter good fat or harmful fat, the communication between the said 2 parties will gradually resume and diabetes will leave us.
Simple but totally contrast against what the scientists believe. Indeed, another set of researches proving the above. Not sure if it is the economic reasons of what blocking the fact from reaching the public.
Wish all of you happy and healthy year of the Horse!
Staying healthy is simple. Keep leaning and train your analytical mind, you will find the answer sooner or later. 😉🫱🏻🫲🏼
https://www.facebook.com/share/1KMWZpLcys/?mibextid=wwXIfr
Major Diabetes Research Breakthrough: Scientists in China have reported promising results using stem-cell–based therapy aimed at restoring insulin production in patients with Type 1 Diabetes and Type 2 Diabetes. In early-stage clinical studies, researchers were able to generate functional insulin-producing pancreatic cells and transplant them into patients — with some participants reportedly reducing or eliminating their need for external insulin.
The therapy works by converting stem cells into pancreatic islet-like cells capable of sensing blood glucose levels and releasing insulin naturally. For Type 1 diabetes — an autoimmune condition where insulin-producing cells are destroyed — this approach aims to biologically replace lost cells. In certain Type 2 cases, restoring insulin production combined with improved metabolic regulation could significantly enhance glucose control.
However, experts stress that while results are highly encouraging, large-scale trials, long-term monitoring, and broader regulatory review are still required before calling it a universal “cure.” Stem-cell therapies must demonstrate durability, safety, and affordability at scale. Still, the possibility of restoring the body’s own insulin production marks one of the most exciting developments in diabetes research in decades.
